Your Partner in Biosimilars Development
Biosimilars mean an increasing opportunity for drug developers but their way to the market involves facing a changing regulatory framework and a complex development process. To successfully navigate these key issues sponsors must work together with an experienced partner.
Linical has the expertise, reach and capabilities to provide full support in biosimilars development. We understand the challenges associated with biosimilars and work with sponsors to ensure the success of the programs.
Our services cover the complete range of Biosimilar development
Insights to successfully navigate Biosimilars’ regulatory environment.
Lean and flexible development plans to ensure operational effectiveness.
Full service, global reach, data driven country and site selection with experience in related indications
Partnership with best-in-class global labs with extensive experience.
Wide Experience in Clinical Trials with Biologics, Supporting Our Clients for More Than 10 Years
Our work spans through main therapeutic areas (Oncology, Haematology, infectious disease, Gastroenterology…) and key indications
All phases with significant experience in Phase III
Worked in main European territories and have an outstanding experience in key markets in Asia with successfully completed Biologic trials in Japan, Korea or Taiwan.
With a flexible approach our team designs strategies to minimize risks and bring Biosimilars to the market in the most cost-effective way possible
Boost your Biosimilar Development
With the right size, right reach and right team, Linical can help you navigate the most complex
aspects related to biosimilars